Both Suliman4 and CRP had higher net benefit than W4SS, which itself surpassed a confirmatory testing for all approach above threshold probabilities of ~6% (equivalent to a number willing to test with confirmatory testing of up to ~15 people per true TB case detected). Here, CRP is linked to tuberculosis.